This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.
Viatris to receive exclusive global development & commercialization rights to 2 Phase 3 assets as well as the potential to add additional assets in the future.
Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.